Bristol-Myers Squibb Co

Bristol-Myers Squibb Co

BMY - NEW YORK STOCK EXCHANGE, INC.

Industry: Pharmaceuticals

Market Cap: 94.5 B

IPO Date: Jul 5, 1929

Country: US

Currency: USD

Shares Outstanding: 2.0 B

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

5/10/2025

Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined $916 million. “Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe,” the statement added.

News

Source: Yahoo

Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label

5/9/2025

Hawaii said on Friday it entered a$700 million settlement with pharmaceutical firm Bristol-MyersSquibb and units of French pharmaceutical company Sanofiin a case about warning labels related to...

News

Source: Finnhub

3 Healthcare Stocks in Hot Water

5/9/2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 13.3%. This drawdown was worse than the S&P 500’s 5.8% fall.

News

Source: Yahoo

Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors

5/8/2025

Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors

News

Source: MarketWatch

A Look at Pharma ETFs After Strong Q1 Earnings

5/8/2025

Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.

News

Source: Yahoo

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

5/8/2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

News

Source: Yahoo

Invesco Dividend Income Fund Q1 2025 Commentary

5/8/2025

The fund outperformed the Russell 1000 Value Index due to strong stock selection in several sectors, despite underperformance in information technology, materials and financials.

News

Source: SeekingAlpha

Invesco Diversified Dividend Fund Q1 2025 Commentary

5/8/2025

In an environment characterized by high uncertainty, we believe investors will place greater emphasis on companies with stable dividends.

News

Source: SeekingAlpha

The Zacks Analyst Blog Highlights Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle

5/8/2025

Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle are part of the Zacks top Analyst Blog.

News

Source: Yahoo

BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit

5/8/2025

BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.

News

Source: SeekingAlpha

Dividend Harvesting Portfolio Week 218: $21,800 Allocated, $2,195.04 In Projected Dividends

5/8/2025

The Dividend Harvesting Portfolio gained 1.98% this week, with a total return of 23.42%. Find out how the portfolio is well-positioned for future rate cuts.

News

Source: SeekingAlpha

Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific

5/7/2025

Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), Bristol-Myers Squibb Co. (BMY) and Canadian Pacific Kansas City Ltd. (CP), as well a micro-cap stock Nova LifeStyle, Inc. (NVFY).

News

Source: Yahoo

Bristol Myers Squibb Says Shareholder Proposal On Request To Cease DEI Efforts Not Approved At Annual Meeting - SEC Filing

5/7/2025

Bristol-Myers Squibb Co: * BRISTOL MYERS SQUIBB CO - SHAREHOLDER PROPOSAL ON REQUESTTOCEASE DEI EFFORTS NOT APPROVED AT ANNUAL MEETING - SEC FILINGSource text:Further company...

News

Source: Finnhub

Improving Access to Care by Strengthening Local Health System Capacity

5/7/2025

NORTHAMPTON, MA / ACCESS Newswire / May 7, 2025 / By Catharine Grimes, President of the Bristol Myers Squibb Foundation We are in an era of unprecedented medical innovation. Scientists are making remarkable progress to diagnose and treat diseases, ...

News

Source: Yahoo

Bristol-Myers Squibb (NYSE:BMY) Appoints Cari Gallman As New General Counsel

5/6/2025

Bristol-Myers Squibb (NYSE:BMY) recently appointed Cari Gallman as the new Executive Vice President, General Counsel, and Chief Policy Officer following Sandra Leung’s retirement. This leadership change might have influenced investors' outlook on the company, contributing to a 3% increase in share price over the last week. However, this movement aligns with the overall market trend, which saw a rise of 2%. Moreover, broader market dynamics, including investor focus on impending Federal...

News

Source: Yahoo

Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors

5/6/2025

Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors

News

Source: MarketWatch

Bristol Myers Squibb announces $40bn US investment plan over five years

5/6/2025

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.

News

Source: Yahoo

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

5/6/2025

PRINCETON, N.J., May 06, 2025--Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

News

Source: Yahoo

Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

5/6/2025

Animal health company Elanco (NYSE:ELAN) will be reporting results tomorrow before market hours. Here’s what to look for.

News

Source: Yahoo

Bristol Myers to invest $40 billion in the US over 5 years

5/5/2025

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on Monday, and was later confirmed to Reuters by a company spokesperson. In the Op-Ed, Boerner said the money will be spread across research and development, technology and domestic manufacturing, as U.S. drugmakers prepare to deal with Trump's tariffs. Trump has repeatedly threatened tariffs on pharmaceutical imports on national security grounds.

News

Source: Yahoo